These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 20184581)

  • 1. Interobserver variability of clinical scores in hidradenitis suppurativa is low.
    Sartorius K; Killasli H; Heilborn J; Jemec GB; Lapins J; Emtestam L
    Br J Dermatol; 2010 Jun; 162(6):1261-8. PubMed ID: 20184581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.
    Sartorius K; Emtestam L; Jemec GB; Lapins J
    Br J Dermatol; 2009 Oct; 161(4):831-9. PubMed ID: 19438453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychophysical aspects of hidradenitis suppurativa.
    Matusiak L; Bieniek A; Szepietowski JC
    Acta Derm Venereol; 2010 May; 90(3):264-8. PubMed ID: 20526543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions.
    Esmann S; Dufour DN; Jemec GB
    Br J Dermatol; 2010 Jul; 163(1):102-6. PubMed ID: 20331444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases.
    Wolkenstein P; Loundou A; Barrau K; Auquier P; Revuz J;
    J Am Acad Dermatol; 2007 Apr; 56(4):621-3. PubMed ID: 17097366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenitis suppurativa markedly decreases quality of life and professional activity.
    Matusiak Ł; Bieniek A; Szepietowski JC
    J Am Acad Dermatol; 2010 Apr; 62(4):706-8, 708.e1. PubMed ID: 20227585
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity.
    Canoui-Poitrine F; Revuz JE; Wolkenstein P; Viallette C; Gabison G; Pouget F; Poli F; Faye O; Bastuji-Garin S
    J Am Acad Dermatol; 2009 Jul; 61(1):51-7. PubMed ID: 19406505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial.
    Pelekanou A; Kanni T; Savva A; Mouktaroudi M; Raftogiannis M; Kotsaki A; Giamarellos-Bourboulis EJ
    Exp Dermatol; 2010 Jun; 19(6):538-40. PubMed ID: 19758320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.
    Fardet L; Dupuy A; Kerob D; Levy A; Allez M; Begon E; Bachelez H; Morel P; Lebbé C
    J Am Acad Dermatol; 2007 Apr; 56(4):624-8. PubMed ID: 17240478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic study of hidradenitis suppurativa following long-pulsed 1064-nm Nd:YAG laser treatment.
    Xu LY; Wright DR; Mahmoud BH; Ozog DM; Mehregan DA; Hamzavi IH
    Arch Dermatol; 2011 Jan; 147(1):21-8. PubMed ID: 20855672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.
    Grant A; Gonzalez T; Montgomery MO; Cardenas V; Kerdel FA
    J Am Acad Dermatol; 2010 Feb; 62(2):205-17. PubMed ID: 20115947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa.
    Kamp S; Fiehn AM; Stenderup K; Rosada C; Pakkenberg B; Kemp K; Dam TN; Jemec GB
    Br J Dermatol; 2011 May; 164(5):1017-22. PubMed ID: 21250966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidradenitis suppurativa in the pediatric population.
    Liy-Wong C; Pope E; Lara-Corrales I
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.
    Włodarek K; Stefaniak A; Matusiak Ł; Szepietowski JC
    Dermatology; 2020; 236(1):8-14. PubMed ID: 31487719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression in patients with hidradenitis suppurativa.
    Onderdijk AJ; van der Zee HH; Esmann S; Lophaven S; Dufour DN; Jemec GB; Boer J
    J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):473-8. PubMed ID: 22339940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM; Armario-Hita JC
    Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hidradenitis suppurativa.
    Revuz J
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):985-98. PubMed ID: 19682181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes.
    van der Zee HH; Jemec GB
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S23-6. PubMed ID: 26470610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.
    Gener G; Canoui-Poitrine F; Revuz JE; Faye O; Poli F; Gabison G; Pouget F; Viallette C; Wolkenstein P; Bastuji-Garin S
    Dermatology; 2009; 219(2):148-54. PubMed ID: 19590173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Painful hidradenitis suppurativa.
    Smith HS; Chao JD; Teitelbaum J
    Clin J Pain; 2010 Jun; 26(5):435-44. PubMed ID: 20473053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.